Susquehanna Fundamental Investments LLC Buys Shares of 50,350 Core Laboratories Inc. (NYSE:CLB)

Susquehanna Fundamental Investments LLC acquired a new stake in Core Laboratories Inc. (NYSE:CLB - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 50,350 shares of the oil and gas company's stock, valued at approximately $872,000. Susquehanna Fundamental Investments LLC owned approximately 0.11% of Core Laboratories at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of CLB. Syon Capital LLC acquired a new stake in shares of Core Laboratories in the fourth quarter valued at approximately $186,000. T. Rowe Price Investment Management Inc. grew its holdings in shares of Core Laboratories by 4.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 1,158,702 shares of the oil and gas company's stock valued at $20,058,000 after buying an additional 46,941 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Core Laboratories by 8.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 36,938 shares of the oil and gas company's stock worth $640,000 after purchasing an additional 2,784 shares during the period. Tower Research Capital LLC TRC raised its holdings in Core Laboratories by 843.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company's stock worth $57,000 after buying an additional 2,936 shares during the period. Finally, MetLife Investment Management LLC lifted its stake in Core Laboratories by 8.8% in the fourth quarter. MetLife Investment Management LLC now owns 29,594 shares of the oil and gas company's stock valued at $512,000 after buying an additional 2,388 shares in the last quarter. 97.81% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CLB shares. Citigroup raised Core Laboratories from a "sell" rating to a "neutral" rating and lifted their price target for the company from $15.00 to $16.00 in a research note on Wednesday, March 12th. StockNews.com downgraded Core Laboratories from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. Finally, Stifel Nicolaus dropped their target price on Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $15.75.

Core Laboratories Stock Performance

NYSE CLB traded down $0.10 during trading on Wednesday, reaching $11.69. 91,976 shares of the company's stock were exchanged, compared to its average volume of 395,650. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. The business has a 50 day moving average price of $13.40 and a 200-day moving average price of $16.84. The stock has a market capitalization of $548.06 million, a P/E ratio of 17.71, a PEG ratio of 0.99 and a beta of 1.45. Core Laboratories Inc. has a fifty-two week low of $10.14 and a fifty-two week high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). The company had revenue of $123.59 million for the quarter, compared to the consensus estimate of $125.09 million. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. The company's revenue for the quarter was down 4.7% compared to the same quarter last year. During the same period last year, the firm earned $0.19 earnings per share. Sell-side analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Monday, May 5th will be given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.34%. The ex-dividend date is Monday, May 5th. Core Laboratories's payout ratio is 6.78%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.